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Tolfenamic Acid (HTA) is a drug which is characterized by very poor water solubility (13.6 nM in acidic 
conditions) and moderate solubility in ethanol (0.17 M). A series of new multicomponent crystals have 
been obtained, by applying mechanochemical methods (i.e. kneading), to mixtures of HTA with sodium 
acetate, sodium carbonate, sodium hydroxide and imidazole. These reactions resulted in two salts 
(NaTA·0.5H2O and NaTA HT Form), a co-crystal of salts (NaTA·HTA·0.5NaAc·2H2O) and two salt 10 
co-crystals (NaTA·HTA·H2O/NaHCO3 and IMH-TA·HTA). Due to the lack of suitable crystals for 
single crystal X-ray diffraction analysis, the structural features of the samples have been characterized by 
solid-state NMR (1H MAS, 13C CPMAS, 1H-13C FSLG LG-CP HETCOR and 15N CPMAS), IR(ATR) 
and Raman spectroscopies, VT-XRPD and elemental analysis. The evaluation of thermal stability and 
dissolution behavior was performed using thermogravimetry, differential scanning calorimetry and 15 
dissolution kinetic tests. The new solid-state forms show better thermal stability than pure HTA and an 
improved dissolution rate, which is most pronounced in NaTA·HTA·H2O/NaHCO3, the NaTA HT 
Form and NaTA·0.5H2O. 
 
Introduction 20 
 Multicomponent crystal formation (salts and co-crystals) is an 
effective means with which to tune the properties of a molecule 
or, in the pharmaceutical field, of an active pharmaceutical 
ingredient (API) by changing its crystal packing.1 A co-crystal is 
a multicomponent molecular crystal; that is, a crystalline 25 
substance formed of two or more chemically different 
molecules.2 Thus solvates, hydrates and both stoichiometric and 
non-stoichiometric lattice inclusion compounds are included in 
this definition.3 With respect to the pure polymorphism 
phenomenon, co-crystal formation provides much more in terms 30 
of possibilities for modulating crystal packing and this is due to 
the choice of two parameters: the co-former and the type of weak 
interaction.4 The use of inorganic salts as co-formers has already 
been explored, by our group, as an effective method for 
producing ionic co-crystals and salt co-crystals of barbituric 35 
acid.5 The difference between ionic co-crystals and salt co-
crystals is found in the type of co-former. Ionic co-crystals are 
formed of an organic molecule and an ionic salt (i.e. alkali halide) 
in the same asymmetric unit, while salt co-crystals are formed of 
an organic molecule and one of its salts in the same asymmetric 40 
unit.6 
 Tolfenamic acid (HTA, 2-[(2-methyl-3-chlorophenyl) amino] 
benzoic acid – Scheme 1) is a drug which belongs to the fenamate 
family. It is a potent, well-tolerated non-steroidal anti-
inflammatory drug (NSAID) which displays low 45 
gastroulcerogenicity,7 low overall toxicity and high therapeutic 
indices as well as analgesic and antipyretic properties.8 Recent 
studies have revealed that it is a Cox-2 inhibitor.9 It is also 
extensively used in both human and veterinary medicine for its 
analgesic and antipyretic properties.10  50 
 A common property of fenamates is their general lack of 
solubility in water and in other common organic solvents 
(obviously their solubility is influenced by their polymorphic 
form)11 thus HTA belongs to class II of the Biopharmaceutics 
Classification System (high permeability in cells and low 55 
solubility in water).12 
 HTA is known to exist in at least five different polymorphic 
forms.13 The most prominent are anhydrous Form I and Form II 
which show very poor water solubility.14 In order to improve the 
water solubility and, thus the biopharmaceutical properties of 60 
HTA, we herein report a synthetic strategy for new HTA co-
crystal forms which is based on mechanochemical and solution 
reactions between HTA, inorganic reagents [NaOH, Na2CO3 and 
sodium acetate (NaAc)] and an organic compound such as 
imidazole (IM). IM is used as a precursor for many 65 
pharmaceutical compounds, but is toxic (LD50 in pig= 760 
mg/kg), and thus not therapeutically used.15 Nevertheless, we 
decided to use IM as model co-former in order to study the 
possibility of an interaction with the COOH group of HTA. 
 70 
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Table 1 Summary of the performed experiments involving HTA and additional components (k = kneading, h= heating). 
Components Preparation Class Formula/Name Ratio 
HTA NaOH Salification salt NaTA polymorphic mixture 1:1 
NaTA mixture k (1-BuOH, THF, DMF, H2O) salt NaTA·0.5 H2O -- 
HTA Na2CO3 k (EtOH/H2O 2:1) 
heterogeneous mixture with a 
salt co-crystal 
NaTA·HTA·H2O/NaHCO3 2:1 
HTA NaAc k (EtOH 99%) co-crystal of salts NaTA·HTA·0.5NaAc·2H2O 2:1.5 
NaTA·0.5H2O or NaTA·HTA 
2H2O/NaHCO3 
 
h (170-180°C) salt NaTA HT form  
HTA IM k (EtOH 99%) salt IMH-TA·HTA 2:1 
 
 
Experimental and methods 
 HTA (Tokyo Chemical Industry Company and Sigma 
Aldrich), Na2CO3, NaOH, IM and NaAc (all Sigma Aldrich) were 5 
used without further purification. 
 The HTA commercial batch was characterized by solid-state 
NMR analysis as pure Form I. HTA Form II was reproduced 
following the method reported in literature16 only for comparison. 
 All samples were obtained via mechanochemical [kneading 10 
with mortar and pestle i.e. grinding with catalytic amount (from 
50 to 150 µl, corresponding to two-six drops) of solvent] and 
solvent techniques.17,2 Experiments performed and products 
obtained are summarized in Table 1. 
 The NaTA polymorphic mixture was prepared by refluxing 15 
128 mg of HTA and 1 ml of NaOH 0.5 M (stoichiometric ratio 
1:1) in 5 ml of absolute EtOH for 3h. 
 NaTA·0.5H2O (salt): A white powder of this hemihydrated 
salt was quantitatively obtained by kneading (H2O; 50 µl) a 
NaTA polymorphic mixture at room temperature for 5 minutes. 20 
NaTA·0.5H2O was also obtained by directly kneading (H2O; 100 
µl) HTA with NaOH. However, this procedure did not allow for 
precise stoichiometric control because the hygroscopic nature of 
NaOH makes correct weighing difficult. [Elem. Anal. Calc. for 
C14H12N1O2.5Cl1Na1: C, 57.45; H, 4.13; N, 4.79; O, 13.67; Cl, 25 
12.11; Na, 7.85 %. Found: C, 57.26; H, 4.29; N, 4.88; O, 13.72; 
Cl, 12.08; Na, 7.77 %.] 
 NaTA·HTA·H2O/NaHCO3: This is a heterogeneous mixture 
between NaTA·HTA and NaHCO3. It was not possible to 
determine whether H2O co-crystallizes with NaTA·HTA or 30 
NaHCO3. It occurs as a white powder and was obtained 
quantitatively by kneading (ethanol/water 2:1; 150 µl) HTA (200 
mg) and Na2CO3 (40.5 mg), stoichiometric ratio 2:1, at room 
temperature for 20 minutes. It was not possible to obtain pure 
NaTA·HTA without NaHCO3 using different starting material 35 
ratios either. The stoichiometric formula: 
NaTA·HTA·H2O/NaHCO3 was confirmed by solid-state NMR, 
thermal analysis and elemental analysis. [Elem. Anal. Calc. for 
C29H28N2O9Cl2Na2: C, 52.34; H, 4.24; N, 4.21; Na, 6.91 %. 
Found: C, 52.47; H, 4.29; N, 4.08; Na, 6.88 %.] 40 
 NaTA·HTA·0.5NaAc ·2H2O: This co-crystal of salts was 
obtained as a white powder and in maximal yield by kneading 
(EtOH 99%, 150 l) stoichiometric ratios (2:1.5) of HTA (200 
mg) and NaAc (90 mg) at room temperature for 20 minutes. 
Solid-state NMR, thermal analysis and elemental analysis 45 
indicated that the formula is NaTA·HTA·0.5NaAc·2H2O. [Elem. 
Anal. Calc. for C29H28.5N2O7Cl2Na2: C, 55.96; H, 4.62; N, 4.50; 
Na, 7.39 %. Found: C, 55.78; H, 4.56; N, 4.69; Na, 7.19 %.] 
 NaTA HT Form (salt): A white powder was obtained after 
heating NaTA·0.5H2O or NaTA·HTA·H2O/NaHCO3 at 170-50 
180°C in a muffle oven (ramp 5°C/min). [Elem. Anal. Calc. for 
C14H11N1O2Cl1Na1: C, 59.27; H, 3.91; N, 4.94; O, 11.28; Cl, 
12.50; Na, 8.10 %. Found: C, 59.07; H, 4.13; N, 4.70; O, 11.46; 
Cl, 12.46; Na, 8.18 %.] 
 IMH-TA·HTA (Salt co-crystal): This product (white powder) 55 
was obtained by kneading HTA (200 mg) and IM (26 mg) in a 
2:1 ratio for 15 minutes in the presence of absolute EtOH (50µl). 
[Elem. Anal. Calc. for C31H28N4O4Cl2: C, 62.95; H, 4.77; N, 9.47 
%. Found: C, 62.87; H, 4.66; N, 9.32 %.] 
Scheme 1 HTA structure with atom labelling. 60 
 All solid-state NMR spectra were recorded with a Bruker 
Avance II 400 instrument operating at 400.23, 100.65 and 40.55 
MHz for 1H, 13C and 15N nuclei, respectively. For 13C and 15N 
CPMAS (Cross Polarization Magic Angle Spinning) spectra, 
cylindrical 4 mm o.d. zirconia rotors with a sample volume of 80 65 
L were employed. Samples were spun at 12 and 9 kHz for 13C 
and 15N, respectively. A ramp cross-polarization pulse sequence 
was used with contact times of 3-5 (13C) or 4 ms (15N), a 1H 90° 
pulse of 3.8 s, recycle delays of 1-60 s and 48-4096 transients 
for 13C and 1598-5956 transients for 15N. Proton spin–lattice 70 
relaxation times, 1H T1, were obtained using the 
13C-detected 
Inversion Recovery Cross Polarization technique [1H(180◦- -
90◦)-CP-13C(FID)], where one measures the 13C magnetization 
that appears through the CP process after the relaxation of 1H 
magnetization over time . 160-1024 transients were acquired and 75 
a variable delay list file (from 22ms to 42s) was used. 2D 13C-1H 
FSLG (Frequency Switched Lee Goldburg) on- and off-resonance 
HETCOR (Heteronuclear Correlation) spectra were measured 
according to the method developed by van Rossum et al.18 The 
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Fig.1 XRPD patterns of HTA and all multiple component crystals. 
MAS rate was set at 12 kHz. The proton rf field strength used 
during the t1 delay for FSLG decoupling and during the 
acquisition for TPPM (Two-Pulse Phase-Modulated) decoupling 5 
was 83 kHz. Two off-resonance pulses with opposite phases (i.e., 
+x, -x or +y, -y) used during the FSLG decoupling were set to 9.8 
μs. The contact time used was 100 μs. The magic angle (54.7°) 
pulse length for protons was set at 2.0 μs, while the recycle delay 
used was 15 s. Quadrature detection was achieved using the 10 
States-TPPI method. All data for 64 t1 increments with 140 scans 
were collected. A B1(
1H) field intensity for the CP of 75 kHz and 
a mixing period of 2.0 ms were used for FSLG off-resonance CP 
(LG-CP) HETCOR NMR. The 1H NMR chemical shift scale in 
the HETCOR  spectra was corrected by a scaling factor of 1/√3 15 
because the 1H NMR chemical-shift dispersion is scaled by a 
factor of 1/√3 during FSLG decoupling. 1H MAS experiments 
were performed on a 2.5 mm Bruker probe at a spinning speed of 
32 kHz. The 1H MAS spectra were acquired using the DEPTH 
sequence ( /2– – ) which suppresses the probe background 20 
signal.19 The 1H 90° pulse length was set to 2.50 s, the recycle 
delays to 1-40 s and 32-64 transients were averaged for all 
samples. 1H, 13C and 15N chemical shifts were referenced via the 
resonance of solid adamantane (1H signal at 1.87 ppm), HMB 
(13C methyl signal at 17.4 ppm) and (NH4)2SO4 (
15N signal at -25 
355.8 ppm with respect to CH3NO2), respectively. 
 IR and Raman spectra were only used to screen the products  
and to monitor reaction conversion. In order to discriminate 
between the different forms, particular attention was given to the 
regions from 3500 to 3300 cm-1 (NH and OH stretching), 3100 30 
and 3000 cm-1 (CH and CH2 stretching) and 1700-1600 cm
-1 
(C=O stretching). All IR and Raman spectra are reported in 
Figures S1 and S2 in the Supporting Information. Fourier 
transform infrared (FTIR) spectra were collected directly on the 
sample using a Bruker IFS 25 spectrometer 35 
(BrukerAnalytischeMesstechnik GmbH, Ettlingen, Germany) 
connected to a Bruker IR microscope I (15x-Cassegrain-
objective). The samples were prepared on ZnSe-disks and 
measured in transmission mode (spectral range 4000-600 cm-1, 
resolution 4 cm-1, 32 interferograms per spectrum).20 Raman 40 
spectra were measured on a Bruker Vertex 70 spectrometer 
equipped with a RAM II using a 1064 nm Nd:YAG source and a 
Ge diode detector (laser power 10-50 mW, spectral resolution 4 
cm-1). 
 Differential Scanning Calorimetry (DSC) was performed on a 45 
TA instrument Q200. Samples (5-10 mg) were placed in sealed 
alumina pans and heated at a rate of 10°C min-1 (temperature 
range: 30 to 400 °C). 
 Thermogravimetric (TGA) measurements were performed 
under N2 flow (heating rate: 10°Cmin
-1) on a TA instrument 50 
Q600 SDT Simultaneous DSC-TGA heat flow analyzer. The 
samples (5-10 mg) were placed in alumina pans. All DSC and 
TGA thermograms are reported in Figures S3 in the Supporting 
Information.  
 X-ray powder diffraction (XRPD) patterns of the samples 55 
under investigation were collected on a PW3050/60 X’Pert PRO 
MPD diffractometer, from PANalytical, working in the Debye-
Scherrer geometry and using, as the source, a high-powered 
ceramic tube PW3373/10 LFF with a Cu anode equipped with a 
Ni filter to attenuate Kb which was focused by a PW3152/63 - 60 
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Scheme 2 Supramolecular Synthons and Hydrogen Bond motif of 
anhydrous HTA Form I and II. 
X ray mirror. Powdered samples were hosted inside a 0.8-mm 
boron silicate capillary and mounted on a rotating goniometer 5 
head.  
 Variable Temperature (VT) XRPD studies were carried out on 
an X-Pert Diffractometer (PANalytical, Cu Kα radiation) 
equipped with a hot-stage and an environmental chamber (Anton 
Paar XRK 900), to analyze the conversion of both NaTA·0.5H2O 10 
and NaTA·HTA·H2O/NaHCO3 to the NaTA HT Form. XRPD 
patterns of HTA Form I, Form II, and all multiple component 
crystals are reported in Figure 1, while XRPD patterns of used 
co-formers, VT-XRPD patterns, used ramps and technical details 
are reported in the Supporting Information (Figures S4 and in 15 
Schemes 1 and 2). 
 Dissolution kinetic tests (DKT) were performed in a pH 7.4 
buffer (0.2 M KH2PO4/0.2 M NaOH). 5 mg of HTA (as a pure 
compound or co-crystal and salt) were added to 150 cm3 of 
dissolution medium at 37°C in each experiment. The release test 20 
lasted 180 min. In these experiments, the solution was kept 
homogeneous using an impeller (rotational speed 200 rpm) and 
the determination of HTA concentration was performed using 
fibreoptic apparatus (HELLMA, Milano, Italy) connected to a 
spectrophotometer (ZEISS, Germany,).21 Measurement was 25 
performed at 286.9 nm (HTA maximum absorption, supporting 
information). Each sample was tested in triplicate. The mother 
solution was obtained by dissolving 100 mg HTA in 100 ml 
methanol. The concentration of the standard solutions obtained 
from the mother solution and the calibration curve are reported in 30 
Figures S5 in the Supporting Information. In this dissolution 
medium, the equilibrium solubility of pure HTA was 28.5 mg/l. 
Elemental analysis was performed on a CHN analyzer (CE 
Instruments, NA2100 Protein), and a Perkin Elmer 3030 flame 
atomic absorption spectrometer (FAAS) for sodium 35 
determination, to clarify the stoichiometry of compounds. The 
data confirm the stoichiometries deducted by solid-state NMR. 
Data are reported in the Experimental and methods section. 
Results and discussion 
 The two anhydrous forms of HTA are characterized by the 40 
presence of a dimer which is connected through the very robust 
(8) carboxylic acid homo-dimeric synthon (Scheme 2), as 
observed in the X-ray structures.22 Such a feature gives rise to a 
single COOH resonance around 175 ppm in the 13C CPMAS 
spectra (Figure 2a and 2b). This is an intermediate value between 45 
typical COOH and COO- chemical shifts ( 173 and 178 ppm, 
respectively).23 The strength of this interaction most likely 
explains the poor water solubility of HTA. Although one example 
of a HTA co-crystal,24 five metal-complexes25 and a calcium salt 
are reported in literature,26 the (8) carboxylic acid homo-50 
dimeric synthon is strong enough to prevent the formation of 
other co-crystals in which the COOH group must be accessible. 
Indeed, the NH group is not particularly suitable for hydrogen 
bond interaction as both the steric hindrance of the methyl and 
COOH groups and the formation of an intramolecular hydrogen 55 
bond with the COOH moiety hamper it. This is probably the main 
reason why it does not form classic organic co-crystals with 
malonic acid, succinic acid, sodium malonate, glycine, L-alanine, 
aspartic acid, sodium glycinate, sodium acetate (NaAc), adenine, 
thymine, guanine and resorcinol. The ionic co-crystal approach,27 60 
using inorganic salts (KI, KF, KBr, NaCl, KBr, KHCO3, K2CO3, 
NaHCO3, AlCl3 e FeCl3,) was also unsuccessful. For this reason 
we decided to use co-formers which are either able to react 
quantitatively with HTA, to form the corresponding salt, or to 
partially salify HTA and form a salt co-crystal such as salts and 65 
bases: NaOH, Na2CO3, NaAc and IM. 
 All samples were obtained via simple kneading. Crystallization 
with different solvents resulted in either a NaTA polymorphic 
mixture or pure HTA Form I or II. Different forms are present in 
the NaTA polymorphic mixture, as shown by the 13C CPMAS 70 
spectrum (Figure S6 in the Supporting Information). Several 
attempts to promote the selective crystallization of single forms 
using various solvents (EtOH, 1- BuOH, THF, DMSO, DMF, 
H2O or CH3CN) failed. Thus, in this case, mechanochemistry 
allowed us to obtain pure compounds. The chemical shifts of the 75 
solid-state NMR spectra of all crystal forms are listed, with 
assignments, in Table 2. 
 
Fig. 2 13C (100 MHz) CPMAS spectra with main the assignments of HTA 
Form I and II, NaTA·0.5H2O, NaTA·HTA·H2O/NaHCO3, 80 
NaTA·HTA·0.5NaAc·2H2O, NaTA HT Form and IMH·TA·HTA 
recorded at 12 kHz. 
 5 
 
Fig. 3 1H (400 MHz) MAS spectra of HTA Form I and II, NaTA·0.5H2O, 
NaTA·HTA·H2O/NaHCO3, NaTA·HTA·0.5NaAc·2H2O, NaTA HT 
Form and IMH-TA·HTA recorded at 32 kHz. 
 NaTA·0.5H2O, prepared in a pure form by kneading 5 
stoichiometric amounts of HTA and NaOH, shows the splitting of 
almost all resonances in the 13C CPMAS spectrum (Figure 2c), 
indicating the presence of two independent molecules in the unit 
cell. The splitting is especially marked for atoms C3, C8 and C14. 
Salification was confirmed by the shift of the carboxylic 10 
resonance from 175.3 ppm (typical of the cyclic dimerization of 
the COOH moieties in pure HTA) to 178.3 ppm, which is 
characteristic of the COO- group. The possible formation of a 
50:50 mixture between two polymorphs was ruled out by 1H T1 
measurements which provided the same value for all 1H atoms. 15 
Indeed, according to a simplified but reliable approach,28 the spin 
diffusion process averages 1H T1 when protons belong to the 
same phase or in the case of homogeneous samples on a 
nanometer scale.29 On the other hand, protons with different 
relaxation times belong to different domains with an average 20 
linear dimension of greater than about 100 Å and vice versa.30 In 
this case all resonances possess the same T1 values, thus, two 
molecules are present in the asymmetric unit. The presence of 
half a water molecule in the structure has been predicted by 
combining data from TGA (see Figures S3 in the Supporting 25 
Information) and integral values of the 1H MAS spectrum (Figure 
3c). This value agrees with the elemental analysis. The NH 
proton chemical shift suggests the presence of the NH···COO- 
intramolecular interaction that characterizes both HTA Form I 
and II and all the crystal forms presented in this paper. 30 
 NaTA·HTA·H2O/NaHCO3 was obtained by kneading HTA 
and Na2CO3 (2:1) with an EtOH/H2O (2:1) mixture used as the 
mediating solvent. This heterogeneous mixture consists of a salt 
co-crystal (concomitant presence of both neutral HTA molecule 
and NaTA salt; NaTA·HTA) and an inorganic salt (NaHCO3) in a 35 
different domain. Any other attempt to change either the 
stoichiometric ratio or grinding conditions yielded a 
heterogeneous mixture of components. The 13C CPMAS 
spectrum (Figure 2d) shows two sets of signals which indicate the 
presence of a HTA and a NaTA molecule in the unit cell. The 40 
carboxylic region of the spectrum is characterized by three peaks 
at 179.3, 170.1 and 164.5 ppm. The two former signals are 
attributed to the COO- (179.3 ppm, NaTA) and COOH (170.1 
ppm, HTA) groups. The latter peak (at 164.5 ppm) is assigned to 
the bicarbonate formed during the reaction. Interestingly, 1H T1 45 
measurements indicate that HTA and TA- signals belong to the 
same phase, which is in agreement with the formation of a salt 
co-crystal, while the NaHCO3 resonance belongs to a different 
domain.30 The 1H MAS spectrum (Figure 3d) is characterized by 
two signals in the hydrogen bond region (14.0 and 12.8 ppm, 50 
integral ratio 1:2) which are attributed to the COOH of HTA and 
NH of HTA and TA-. TGA and 1H integral values suggest the 
presence of one molecule of H2O which is in agreement with the 
elemental analysis. However, it was not possible to establish 
whether the water is associated with the salt co-crystal or 55 
NaHCO3. 
 NaTA·HTA·0.5NaAc·2H2O was obtained as a pure compound 
via kneading (EtOH 99%) HTA with NaAc. The 
carboxylic/carboxylate region of the 13C solid-state NMR 
spectrum (Figure 2e) reveals the number of independent 60 
molecules in the unit cell and revealed the presence of one HTA 
(δCOOH= 175.9 ppm), one NaTA (δCOO-= 179.0 ppm) and one 
NaAc (δCOO-= 184.7 ppm) in a 1:1:0.5 ratio. The signals due to 
the NaAc are only slightly shifted from the pure compound 
values, indicating a weak interaction with NaTA·HTA (184.7 and 65 
22.8 ppm in NaTA·HTA·0.5NaAc·2H2O with respect to 183.5 
and 26.7 ppm in pure NaAc). The 1H MAS spectrum (Figure 3e) 
shows two resonances in the weak hydrogen bond region at 10.8 
and 8.6 ppm (ratio 2:1), which are assigned to COOH and NH 
proton and to the other NH proton (overlapped with aromatic 70 
resonances), respectively. By evaluating the 1H integration, we 
can assume the presence of two molecules of water in the 
structure, as confirmed by TGA and elemental analysis. The final 
composition is: NaTA·HTA·0.5NaAc·2H2O. The same 
1H-T1 
value for all the protons confirms that the best definition for 75 
describing such structure is a co-crystal of salts 
(NaTA·HTA·0.5NaAc·2H2O), because the solid is composed of 
a salt co-crystal (NaTA·HTA) and a salt (NaAc).  1H-13C FSLG 
on- and off-resonance CP HETCOR experiments were performed 
in order to obtain a deeper understanding of the spatial 80 
proximities and to complete the assignment of the strongly 
overlapped 1H resonances. The spectra are reported in Figures S7 
(Supporting Information) and Figure 4, respectively. These 
experiments allow intra- and intermolecular heteronuclear 
correlations to be obtained.31,18 By acquiring 2D experiments 85 
with short or long contact times (100 and 2000 µs, respectively), 
it is possible to discriminate between short- (single bond) and 
long-range spatial proximities, respectively. In particular, the use 
of off-resonance CP (LG-CP) allows for a more detailed analysis  
 6 
Table 21H, 13C and 15N chemical shifts with assignments for all obtained compounds and pure IM and HTA Form I and II. 
Note 
HTA 
Form I 
HTA 
Form II 
NaTA 
·0.5 
H2O 
NaTA·HTA 
·H2O/NaHCO3 
NaTA·HTA·0.5
NaAc·2H2O 
NaTA HT 
Form 
IMH-
TA·HTA 
IM 
13C CPMAS 
C1 175.4 175.5 178.3 179.3 179.0 178.9 175.7 -- 
   170.1 175.9  174.3  
C2 109.4 108.2 118.4 114.2 114.0 111.7 113.4 -- 
   111.4   112.2  
CHAr/CHIM 136.2 132.8sh 134.6 136.3 133.3 133.4 133.9 137.0 
135.0 125.0 127.0 132.5 128.0 132.5 133.1 127.3 
130.1 123.6 125.4 130.5 117.1 128.4 131.3 115.7 
129.4 122.9 122.8 120.2 116.7 127.9 127.4  
127.8 117.8 120.2 117.9  127.1 126.1  
116.6 116.6  115.7  125.4 117.6  
112.1 111.9    121.9 115.8  
     120.2   
     118.7   
C9 133.6 125.9 131.3 134.0 130.4 128.4 124.0 -- 
   127.7  or 127.1 120.6  
C10 137.0 136.3 137.8 139.4; 136.2; 134.7 139.9 -- 
136.1   138.2 135.5  136.2  
C3 150.4 146.9 147.3 150.5 151.7sh 147.0 148.8 -- 
  145.6  151.1  146.9  
C8 138.9 138.7 141.9 147.5 142.4sh 140.5 141.4 -- 
  140.5  141.9    
C14 15.6 14.6 15.4 16.4 19.3 14.7 14.7 -- 
  13.4 15.6 16.0  13.9  
      13.2  
Ca -- -- -- 164.5b 184.7c -- -- -- 
    22.8   
15N CPMAS 
NH 66.5 -- 72.2 66.1 -- 64.6 71.7 -- 
  70.8 60.4   67.6  
      62.5  
      59.1sh  
NH+IM/NIM 
NHIM 
-- -- -- -- -- -- 153.2d 220.5
e 
NHIM -- -- -- -- -- -- 145.5 149.2 
1H MAS 
COOH 12.8 12.9 -- 14.0 10.8 -- 15.4 -- 
   12.8     
NH 8.8sh 8.9sh 9.3 14.0 10.8 9.8 10.4 -- 
   12.8 8.6sh    
CHAr/CHIM 7.1 7.0 7.5 6.6 7.5 6.4 8.5 7.2 
 6.0 6.7 6.4  6.7  6.5  
CH3 1.4 1.6 1.7 1.5 1.3 
1.2 
0.9 
1.7 1.4 -- 
H2O -- -- 4.2 6.7 1.3 -- -- 2.8 
NH+IM -- -- -- -- -- -- 20.2 
19.5 
-- 
NHIM -- -- -- -- -- -- 15.4 14.7 
 
aCarbon atoms of either molecules in other phases or of solvents or of co-former molecules. b NaHCO3. 
c NaAc. d NH+IM. 
e NIM. 
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Fig. 4 1H-13C FSLG LG-CP HETCOR spectrum of 
NaTA·HTA·0.5NaAc·2H2O acquired with a contact time of 
2000 µs with relevant assignments. Intramolecular and 
intermolecular correlations are indicated in red and light blue, 
respectively. 5 
 
of long range spatial 1H-13C contacts. This is achieved using a 
Lee-Goldburg (LG) spin-lock (LG-CP) which efficiently 
suppresses unwanted 1H–1H spin exchange which leads to fake 
correlation peaks that reflect 1H-1H homonuclear rather than 1H-10 
13C heteronuclear dipolar couplings.32,18 All 1H-13C proximities 
are depicted in Scheme 3. The 1H-13C FSLG LG-CP HETCOR 
experiment (Figure 4), allowed us to establish the presence of an 
intramolecular NH O-C hydrogen bond in the NaTA molecule  
15 
Scheme 3 1H-13C correlations between HTA, NaTA and NaAc in 
NaTA·HTA·0.5NaAc·2H2O as deduced from 
1H-13C FSLG LG-
CP HETCOR. 
 
(correlation between the 1H NH signal at 8.6 ppm and the 13C 20 
COO- at 179 ppm). The lack of a similar correlation between 
signals assigned to the HTA molecule points to a non-planar 
conformation of the two rings for this molecule. On the other 
hand, the HTA OH proton (10.8 ppm) correlates with the COO- 
carbon of NaTA (179.0 ppm), indicating that the two groups are 25 
involved in a O-H O hydrogen bond. Other correlations were 
found for the NH hydrogen of NaTA (8.6 ppm) with the NaAc 
methyl and carboxylate carbons (22.8 and 184.7 ppm, 
respectively). Finally, polarization transfer is observed from the 
1H HTA OH (10.8 ppm) to the NaAc methyl (22.8 ppm). 30 
 NaTA HT Form - It is possible to obtain an anhydrous high 
temperature form, called the NaTA HT Form which is also 
stable at room temperature, via heating both NaTA·0.5H2O and 
NaTA·HTA·H2O/NaHCO3 in a oven at around 180°C. However, 
heating NaTA·HTA·0.5NaAc·2H2O results in a mixture of 35 
phases, as observed by 13C CPMAS NMR (see Figure S8 in the 
Supporting Information). The formation of the new form (NaTA 
HT Form) involves the dehydration of NaTA·0.5H2O (release of 
water and formation of NaTA) and the complete salification of 
the HTA molecule in NaTA·HTA·H2O/NaHCO3 after the 40 
bicarbonate decomposes to CO2 and H2O. A combination of 
13C 
and 15N CPMAS data made it possible to reveal the presence of 
only one NaTA molecule in the unit cell. The shift to 178.9 ppm 
in the 13C spectrum (Figure 2f) confirms the presence of COO- 
groups, while the small NH shift (from 66.5, HTA, to 64.6 ppm, 45 
NaTA) indicates a slight rearrangement of the weak 
intramolecular hydrogen bond which involves the NH. This is in 
agreement with the 1H MAS spectrum (Figure 3f) where the NH 
group falls at 9.8 ppm. 
 The solid-state conversions of NaTA·0.5H2O and 50 
NaTA·HTA·H2O/NaHCO3 to NaTA HT Form were also 
followed by VT-XRPD (Figure S4, Schemes 1 and 2). The 5-40° 
2  range was used to evaluate the most significant changes in the 
patterns. In particular, NaTA·0.5H2O is characterized by five 
principal reflections at 9.58, 12.57, 29.76°, which all disappear at 55 
60°C, and at 15.77 and 19.45°, which vanish at 190°C. The 
appearance of three principal new reflections at 14.70, 17.63 and 
20.51°, at the same temperature, points to the formation of the 
NaTA HT Form. On the other hand, NaTA·HTA·H2O/NaHCO3 
is characterized by reflections at 12.42, 17.38 and 18.34°, plus the 60 
signals attributed to NaHCO3 (at 30.43 and 34.39°). Upon 
increasing the temperature to 190°C, the reflection at 17.38° 
decreases in intensity while all the others disappear, giving the 
characteristic signals of the NaTA HT Form. The disappearance 
of the NaHCO3 signals agrees with the salification of HTA by the 65 
bicarbonate.  
 IMH-TA·HTA was obtained by kneading (EtOH 99%) HTA 
and IM in a 2:1 ratio. Two TA- and two HTA independent 
molecules are present in the unit cell as shown by the 13C 
CPMAS spectrum (Figure 2g), which is characterized by the 70 
splitting of the C1 (175.7 and 174.3 ppm in 3:1 ratio) and C14 
(14.7, 13.9 and 13.2 ppm in 1:2:1 ratio) signals. This is also 
confirmed by 15N CPMAS (Figure 5) where four peaks, caused 
by the NH group (71.7, 67.6, 62.6 and 59.1sh ppm), are clearly 
observable. The number of IM molecules is determined, in this 75 
case, by 15N CPMAS because the IM 13C resonances fall under 
the aromatic CH of the TA-/HTA molecules. The estimated 
number of independent IM molecules is two (15N δNH=153.2 and 
145.5 ppm). The observed shifts for the IM NH resonances (from 
220.5 and 149.2 ppm to 153.2 and 145.5 for N and NH, 80 
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Fig. 5 15N (40.56 Hz) CPMAS of HTA Form I, IMH-TA·HTA 
and pure IM recorded at 9kHz. 
 
respectively) suggest that the IM is present in the protonated form 
(imidazolium, IMH+) as has already been reported in literature.33 5 
This implies that the proton transfer occurs from one HTA 
(becoming TA-) to the IM (becoming IMH+). The similarity 
between COOH and COO- 13C chemical shifts may suggest that 
an interaction between two groups is able to delocalize the 
negative charge. It is possible to note, from 1H MAS (Figure 3g), 10 
that the IMH+ NH+ groups form very strong hydrogen bonds 
(20.2 and 19.5 ppm), while the IMH+ NH and the HTA COOH 
hydrogen atoms, both involved in hydrogen bonds, fall at the 
same chemical shift (15.4 ppm). For HTA, as in the 1H MAS 
spectra of the other samples, the NH hydrogen is located at 10.4 15 
ppm. 
Infrared and Raman Spectroscopy 
 The Raman and FT-IR spectra of all prepared samples are 
shown in Figures S1 and S2 in the Supporting Information. 
 The Raman spectra show clear differences in almost all 20 
spectral regions. The most important differences can be found in 
the COOH/COO- frequency range (1750-1550 cm-1), reflecting 
the differences in hydrogen bonding interactions and salt 
formation. In particular, COOH groups are characterized by  and 
 around 1680 and 890 cm-1, respectively. On the other hand, 25 
aCOO
- and sCOO
- are at about 1610 and 1385 cm-1, 
respectively. Other differences are found in the NH and aromatic 
CH stretching regions (3500-3050 and 3000-2800 cm-1, 
respectively). The frequencies of some characteristic bands of the 
solid-state MIR spectra of the polymorphs and multiple 30 
component crystals are listed in Table 3. 
Differential Scanning Calorimetry (DSC) and 
Thermogravimetric (TGA) Analysis 
 All compounds were investigated using TGA and DSC in 
order to characterize thermal behavior and to determine the water 35 
molecule ratios in the samples. Results are listed in Table 4, 
while all DSC and TGA figures are displayed in Figure S3 in the 
Supporting Information. 
 Heating both NaTA·0.5H2O and NaTA·HTA·H2O/NaHCO3 
in an oven at 180°C yielded the same polymorphic form (NaTA 40 
HT Form). In the case of NaTA·HTA·0.5NaAc·2H2O, water 
release (around 160 °C) is followed by the loss (sublimation) of 
one HTA molecule (at 182.6°C) that leads to mixtures of 
anhydrous phases of NaTA and NaAc, as confirmed by 13C 
CPMAS spectra (see Figure S7 in the Supporting Information). 45 
 It is worth noting that the melting and/or decomposition point 
of all samples, except IMH-TA·HTA, are found between 320-
339 °C (pure HTA sublimates around 212 °C followed by 
decomposition) indicating that multicomponent HTA crystals 
exhibit significantly improved thermal stability over single 50 
component forms of HTA. 
Table 3 Wavenumbers (cm-1) of characteristic MIR vibrations with assignments for all multiple component crystals and two HTA polymorphs. 
 
HTA 
FormI 
HTA 
FormII 
NaTA·0.5 H2O 
NaTA·HTA 
·H2O/NaHCO3  
NaTA·HTA·0.5N
aAc·2H2O 
NaTA 
HT Form 
IMH-
TA·HTA 
NH 3340,s 3326,s 
3343,3255 
broad 
3279,m 3312,s 
3367.5,s3243
.7, 
broad 
3290,s 
Ar-CH 
3083-2870 
w 
3078-2914 
w 
3078-2859 
w broad 
2676-2388 
w broad 
3075-2934 
w 
- 
3110-2586 
broad 
(CO)OH 
2736-2493 
w broad 
2733-2487 
w 
- - 
2740-2591 
w 
- - 
(CO)OH 900,s 886,m - - 884,m - - 
CO(OH) 1660,s 1668,s - 1689,s 1775w,1727vs - - 
aCO(O
-) - - 1610,s 1611,s - 1608.4,s 1579.7,s 
sCO(O
-) - - 1388,s 
1391,1378 
broad 
- 1379.2,s 1385.4,w 
CCl 778,751,m 743,m 756,m 758,m 750,m 752.8,m 752.1,m 
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Table 4 TGA and DSC data for all achieved samples. TH2O: dehydration 
temperature, Ttrans: transition temperature, Tfus: melting temperature, Tdec: 
decomposition temperature. 
Sample TH2O Ttrans Tfus Tdec 
HTA -- -- 210-214 
NaTA·0.5H2O 158.5 67.3, 92.3,191.4
a 320.9 
NaTA·HTA 
·H2O/NaHCO3 
-- 136.6,160.6b 
247.
5 
339.
1 
NaTA·HTA 
·0.5NaAc·2H2O 
158.0 182.6c 334.1 
IMH-TA·HTA -- 109.7 181-213 
 
a solid-solid transitions (see Supporting Information). bCO2 and H2O 
release due to the HTA salification. c release of HTA. 5 
 
Dissolution kinetic tests (DKT) 
 In order to confirm that the co-crystallization process is a 
successful strategy for the improvement of the dissolution 
properties of HTA, the in vitro dissolution performance of pure 10 
HTA and various salts and co-crystals were evaluated. Due to its 
acidic character, the solubility of HTA depends on the pH of the 
aqueous medium. In fact, it is reported that the solubility of this 
drug in a pH 1.2 buffer is about 13.6 nM.34 It is very difficult to 
detect such extremely low concentrations of HTA using the UV 15 
method. Therefore, in the present study a pH 7.4 buffer (where 
HTA is more soluble) is used as a dissolution medium. The 
solubility profiles of pure HTA and selected composites are 
reported in Figure 6 (see Figure S9 in the Supporting information 
for the complete profile). 20 
 
 
Fig. 6 Dissolution rate profiles of the samples measured in the first 15 
minutes: HTA (red line with red circles), NaTA·0.5H2O (blue line with 
blue squares), NaTA HT Form (black line with yellow circles), IMH-25 
TA·HTA (green line with green triangles), NaTA·HTA·H2O/NaHCO3· 
(black line with black triangles) and NaTA·HTA·0.5NaAc·2H2O (black 
line with white circles). 
Table 5 Dissolution data: amount (mg/l) of dissolved or released HTA 
calculated after 1, 15 and 180 minutes with the respective percentage of 30 
solubilized sample. 
Sample 
after 
1’ 
% 
after 
15’ 
% 
after 
180’ 
% 
HTA 0.0 0.0 7.3 21.8 28.5 85.4 
NaTA·0.5 H2O 33.0 98.9 33.3 99.8 33.4 100 
NaTA·HTA· 
H2O/NaHCO3 
26.1 78.4 32.3 96.8 33.3 100 
NaTA·HTA· 
0.5NaAc·2H2O 
3.7 11.4 19.7 59.1 25.7 77.2 
NaTA HT 
Form 
32.1 96.2 33.5 99.8 33.2 99.4 
IMH-TA·HTA 0.3 1 5.3 15.8 24.1 72.4 
 
 
 Pure HTA shows the typical dissolution profile of a poorly 
soluble drug: the amount of the drug solubilized remains very low 
in the first 30 minutes of analysis and increases linearly (due to 35 
the protonation phenomenon) in the following part of the 
dissolution test. Figure 6 shows that the dissolution profile of 
IMH-TA·HTA is very similar to the dissolution profile of pure 
 
Table 6 Concentration C (mg/l), AUC values (mg/l·h) and Frel of all the 40 
samples reported for 180, 70 and 15 minutes. 
Sample AUC0-180 S.D. Frel dFrel 
HTA 48.6 3.7 -- -- 
NaTA·0.5H2O 99.8 2.0 2.1 0.2 
NaTA·HTA·H2O/ 
NaHCO3 
98.6 3.0 2.0 0.5 
NaTA·HTA·0.5NaAc·2H2O 54.6 13.8 1.1 0.3 
NaTA HT Form 99.7 4.0 2.1 0.2 
IMH-TA·HTA 42.9 5.2 0.9 0.1 
 
 
HTA. Better results are obtained by NaTA·HTA·0.5NaAc·2H2O, 
especially in the first part of the analysis (up to 90 minutes), 
where HTA solubilizes in higher amounts. In the case of 45 
NaTA·0.5H2O and the NaTA HT Form, instantaneous HTA 
solubilization is observed. In fact, HTA solubilizes completely in 
the first minute of the dissolution test and high concentrations are 
maintained throughout. Moreover, no precipitation phenomenon 
is observed in the dissolution profiles of these forms. It is also 50 
worth noting that NaTA·HTA·H2O/NaHCO3 is completely 
dissolved in only 15 minutes of analysis, like the NaTA salts 
(Figure 6). Table 5 lists the data extrapolated after a dissolution 
time of 1 and 15 minutes. These data highlight how the active 
component is liberated from the multicomponent samples, and 55 
that this process is strongly accelerated not only in the salts but 
also in NaTA·HTA·H2O/NaHCO3. 
 Subsequently, FDA bioequivalence limits were adopted and 
used for the in vitro solubilization experiments in order to make a 
comparison between the performed samples. In more detail, FDA 60 
guidance suggests that two compounds/formulations can be 
considered bioequivalent if the ratio of their Area Under the 
Curve (AUC) is in the 0.80-1.25 interval.35 This evaluation 
parameter is proposed for in vivo studies, but it has been 
DKT
0
5
10
15
20
25
30
35
40
0 2 4 6 8 10 12 14
Time (min)
m
g
/l
HTA Form I
NaTA*H2O
NaTA*HTA Formulation
HTA CCS
NaTA HT Form
IMTA*HTA
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successfully applied to compare AUC values obtained from in 
vitro data.21. 
 For each sample (pure HTA Form I, HTA salts and HTA co-
crystals), AUC was calculated from time 0 to the last measured 
point (AUC0-180), using the classical trapezoidal method. The 5 
AUC of HTA was then used as the reference and indicated as 
AUCref. Furthermore, the ratio (indicated as Frel) between the 
AUC of each formulation (AUCsample) and AUCref was calculated, 
as follows: 
  (I) 10 
 The associated uncertainty (indicated as dFrel) for all Frel 
ratios was calculated using the classic formula for the relative 
error of a ratio:36 
 (II) 
 15 
 where dAUCsample and dAUCref indicate the S.D. of the 
AUCsample and AUCref values, respectively. The calculated Frel ± 
dFrel values are listed in Table 6. 
 It can be seen from Table 6 that IMH-TA·HTA and 
NaTA·HTA·0.5NaAc·2H2O are bioequivalent with pure HTA in 20 
vitro. The other products are probably more bioavailable than 
pure HTA (Table 6). These results confirm that co-crystallization 
is an efficient and innovative technique with which to improve 
the biopharmaceutical performance of poorly soluble drugs. 
Conclusions 25 
 Three new multicomponent crystals of tolfenamic acid 
(NaTA·HTA·H2O/NaHCO3, NaTA·HTA·0.5NaAc·2H2O and 
IMH-TA·HTA) and two sodium salts (NaTA·0.5H2O and NaTA 
HT Form) have been prepared using mechanochemical 
techniques (see Scheme 4). The stoichiometries of the samples 30 
were successfully elucidated using a combination of solid-state 
NMR and TGA data, due to a lack of single crystal XRD 
analysis. The results are consistent with elemental analysis data. 
This study thus highlights the great potential that solid-state 
NMR techniques possess when analyzing the composition and 35 
structural characteristics of complex multi-component crystals,37 
for which it may difficult or impossible to acquire single crystal 
structure data. Indeed, important structural information 
(asymmetric unit, salt or co-crystal formation, weak interactions, 
molecule proximities, hydration degree...) for the samples was 40 
provided by 1D and 2D solid-state NMR experiments. 
 
Scheme 4 Representation of the preparation paths. k = kneading,  = 
heating. 
 Mechanochemistry is a successful method for producing new 45 
solid-state forms. One big advantage that this technique provides 
is the fact that it gives pure products that do not require further 
purification. 
 The peculiarities of these HTA derivatives are the following: 
- Heating NaTA·0.5H2O and NaTA·HTA·H2O/NaHCO3 50 
results in the same NaTA HT Form, as confirmed by solid-state 
NMR and RAMAN spectroscopy as well as by VT-XRPD 
measurements. The transformation of the salt hydrate only 
involves a dehydration process while the transformation of the 
NaTA·HTA·H2O/NaHCO3· to the NaTA HT Form includes a 55 
salification reaction between the HTA of NaTA·HTA and 
NaHCO3, which releases CO2 and H2O. 
- NaTA·HTA·0.5NaAc·2H2O behaves differently upon heating 
and loses HTA to yield a NaTA + NaAc mixture, as characterized 
by solid-state NMR data. 60 
- All samples show increased thermal stability and improved 
solubility behavior (especially the NaTA HT Form, 
NaTA·HTA·H2O/NaHCO3· and NaTA·0.5H2O). All the 
samples showed this trend for the first ten minutes, while 
NaTA·HTA·0.5NaAc·2H2O and IMH-TA·HTA were found to 65 
be less soluble than pure HTA, but only after 180 minutes. 
 This investigation has also demonstrated that the Crystal 
Engineering approach makes it possible to change, and in these 
cases improve, the macroscopic properties (dissolution profile 
and thermal behavior) of an active pharmaceutical ingredient. 70 
Dissolution studies confirm that co-crystallization is an efficient 
and innovative technique with which to improve the 
biopharmaceutical performance of poorly soluble drugs. 
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Figures S1: Raman spectra of all prepared compounds. 
 
 
 
a) Raman spectrum of HTA Form I. 
 
 
b) Raman spectrum of HTA Form II. 
 
c) Raman spectrum of NaTA·0.5 H2O. 
 
 
d) Raman spectrum of NaTA HT Form 
 
 
e) Raman spectrum of NaTA·HTA·H2O/NaHCO3. 
 
f) Raman spectrum of NaTA·HTA·0.5NaAc·2H2O. 
 
 
g) Raman spectrum of IMH-TA·HTA. 
 
 
Figures S2: IR-ATR spectra of all prepared compounds 
 
a) IR (KBr) spectrum of HTA Form I. 
 
b) IR (KBr) spectrum of HTA Form II. 
 
 
c) IR (KBr) spectrum of NaTA·0.5H2O. 
 
d) IR (ATR) spectrum of NaTA HT Form. 
 
e) IR (KBr) spectrum of NaTA·HTA·H2O/NaHCO3. 
 
 
f) IR (KBr) spectrum of NaHCO3. 
 
 
g) IR (KBr) spectrum of NaTA·HTA·0.5NaAc·2H2O. 
 
h) IR (KBr) spectrum of IMH-TA·HTA. 
 
i) IR (KBr) spectrum of Imidazole (IM). 
 
 
 
  
Figures S3: Calorimetric and Thermogravimetric curves of all compounds 
 
a) DSC and TGA curves of HTA Form I (batch) 
 
b) DSC curve of HTA Form II (the Form I  Form II conversion reported in 
literature was not observed) 
 
c) DSC and TGA curves of NaTA·0.5H2O.The TGA curve of NaTA0.5H2O 
shows two steps attributed to adsorbed and stoichiometric H2O loss, 
respectively. The DSC is quite complex since presents solid-solid transitions 
at 67.3 and 92.3°C leading to polymorphic mixtures as observed by 13C 
CPMAS measurements (Figure S9) acquired on heated samples. On the 
other hand, the peak at 191.4 is assigned to the formation of NaTA HT 
Form. 
 
d) DSC and TGA curves of NaTA·HTA·H2O/NaHCO3. The two steps 
observed in the TGA curve are assigned to the release of CO2 and H2O, 
respectively. The high temperature regions (above 200°C) of TGA and DSC 
of NaTA·HTA·H2O/NaHCO3 is different from those of NaTA·0.5H2O even if 
they both lead to HTA HT Form (as confirmed by 13C CPMAS spectra). This 
is probably due to the different heating methods used or to the presence of 
small amount of impurities. 
.
 
e) DSC and TGA curves of NaTA·HTA·0.5NaAc·2H2O. 
 
f) DSC and TGA curves of IMH-TA·HTA. 
Figures S4: XRPD patterns of co-formers of HTA. 
 
a) Experimental pattern of NaHCO3. 
 
 
 
 
b) Experimental pattern of Sodium Acetate (NaAc). 
 
 
 
c) Experimental pattern of imidazole (IM). 
 
 
 
 
Scheme 1: Temperature ramp applied to NaTA·0.5 H2O 
 
 
k) VT XRPD patterns of NaTA·0.5 H2O from 25°C (r.t.) to 210 °C. 
 
Scheme 2: Temperature ramp applied to NaTA·HTA·H2O/NaHCO3 
 
 
l) VT XRPD patterns of NaTA·HTA·H2O/NaHCO3 from r.t. (25°C) to 225 °C. 
 
m) XRPD comparison between NaTA·HTA·H2O/NaHCO3 (after heating at 
225°C), NaTA·0.5 H2O (after heating at 210°C) and NaTA HT Form  
A Variable Temperature (VT) XRPD study was performed and reported in 
Figures S3-c and S3-d for NaTA·0.5 H2O and NaTA·HTA·H2O/NaHCO3, 
respectively). The ramp programs (Schemes 1 and 2) were set according to 
the most significant thermal transitions observed in the DSC and TGA data. 
The temperature was alternatively increased and decreased in order to 
check the irreversibility of the conversion processes. The VT XRPD analysis 
confirms the conversion of both NaTA·0.5 H2O and NaTA HTA 
H2O/NaHCO3 into the same NaTA HT Form, in agreement with the solid-
state NMR and RAMAN characterization. 
 
Figures S5: Dissolution kinetic tests (DKT) 
Table 1: Standard solutions of pure HTA for the calibration curve 
Solution Conc (mg/l) ABS 
1 4.00E-01 1.68E+00 
2 1.00E-01 4.63E-01 
3 1.00E-00 6.49E-02 
4 1.00E-01 2.01E-02 
5 1.00E-02 1.25E-02 
6 1.00E-03 2.08E-02 
 
UV absorption spectrum of Solution 2. 
 
Calibration Curve of HTA at 286.9 nm 
 
  
Figure S6: 13C CP MAS of NaTA polymorphs mixture. 13C CPMAS 
spectrum of NaTA polymorphic mixture obtained from HTA salification 
with NaOH; multiplicity and bandwidth of the signals highlight the co-
presence of different polymorphic forms of NaTA. 
 
 
 
 
 
 
 
 
 
 
 
Figure S7: 2D 1H-13C FSLG on-resonance HETCOR spectrum of 
NaTA·HTA·0.5NaAc·2H2O. 2D experiment acquired with a short contact 
times (100 µs) for highlighting only the short- (single bond) spatial 
proximities. 
 
 
 
 
 
 
  
Figure S8: 13C CPMAS of NaTA·HTA·0.5NaAc·2H2O after thermal 
treatment. 13C (100 MHz) CPMAS spectra of a) sodium acetate (batch of 
Sigma Aldrich), b) NaTA·HTA·0.5NaAc·2H2O, c) NaTA·HTA·0.5NaAc·2H2O 
heated at 150°C and d) NaTA·HTA·0.5NaAc·2H2O heated at 250°C 
recorded at 12 kHz. 
 
 
 
  
 
Figure S9: Dissolution rate profiles of the samples. HTA (red line with red 
circle), NaTA·0.5H2O (blue line with blue square), NaTA HT Form (black 
line with yellow circle), IMH-TA·HTA (green line with green triangle), 
NaTA·HTA·H2O/Na2CO3· (black line with black triangle) and 
NaTA·HTA·0.5NaAc·2H2O (black line with white circle respectively) 
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